These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 34073629)
1. The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications. Tsai CY; Hsieh SC; Liu CW; Lu CH; Liao HT; Chen MH; Li KJ; Wu CH; Shen CY; Kuo YM; Yu CL Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073629 [TBL] [Abstract][Full Text] [Related]
2. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. Curran AM; Naik P; Giles JT; Darrah E Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463 [TBL] [Abstract][Full Text] [Related]
3. Macrophage extracellular traps require peptidylarginine deiminase 2 and 4 and are a source of citrullinated antigens bound by rheumatoid arthritis autoantibodies. Bashar SJ; Holmes CL; Shelef MA Front Immunol; 2024; 15():1167362. PubMed ID: 38476240 [TBL] [Abstract][Full Text] [Related]
4. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Miao CG; Yang YY; He X; Li XF; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J Cell Signal; 2013 Oct; 25(10):2069-78. PubMed ID: 23602936 [TBL] [Abstract][Full Text] [Related]
5. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients. Li B; Li P; Bi L Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185 [TBL] [Abstract][Full Text] [Related]
8. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage. Romero V; Darrah E; Andrade F Arthritis Rheumatol; 2020 Jun; 72(6):912-918. PubMed ID: 31876120 [TBL] [Abstract][Full Text] [Related]
9. Crosstalk between B cells and neutrophils in rheumatoid arthritis. Karmakar U; Vermeren S Immunology; 2021 Dec; 164(4):689-700. PubMed ID: 34478165 [TBL] [Abstract][Full Text] [Related]
10. The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels. Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Cabral AR; Llorente L Clin Rheumatol; 2016 Jan; 35(1):55-61. PubMed ID: 26255191 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of non-coding RNAs in Rheumatoid arthritis. Taheri M; Eghtedarian R; Dinger ME; Ghafouri-Fard S Biomed Pharmacother; 2020 Oct; 130():110617. PubMed ID: 32781359 [TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model. Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586 [TBL] [Abstract][Full Text] [Related]
13. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice. Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598 [TBL] [Abstract][Full Text] [Related]
14. [Peptidylarginine deiminase type4 (PADI4) role in immune system]. Seri Y; Shoda H; Matsumoto I; Sumida T; Fujio K; Yamamoto K Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(3):154-9. PubMed ID: 24974927 [TBL] [Abstract][Full Text] [Related]
15. LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis. Bi X; Guo XH; Mo BY; Wang ML; Luo XQ; Chen YX; Liu F; Olsen N; Pan YF; Zheng SG EBioMedicine; 2019 Dec; 50():408-420. PubMed ID: 31791845 [TBL] [Abstract][Full Text] [Related]
16. Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis. Mousavi MJ; Jamshidi A; Chopra A; Aslani S; Akhlaghi M; Mahmoudi M J Cell Physiol; 2018 Jan; 234(1):335-347. PubMed ID: 30069877 [TBL] [Abstract][Full Text] [Related]
17. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468 [TBL] [Abstract][Full Text] [Related]
18. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3. Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis. Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F Front Immunol; 2018; 9():2696. PubMed ID: 30515171 [No Abstract] [Full Text] [Related]
20. Epigenetics in rheumatoid arthritis; fibroblast-like synoviocytes as an emerging paradigm in the pathogenesis of the disease. Karami J; Aslani S; Tahmasebi MN; Mousavi MJ; Sharafat Vaziri A; Jamshidi A; Farhadi E; Mahmoudi M Immunol Cell Biol; 2020 Mar; 98(3):171-186. PubMed ID: 31856314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]